Publication Detail

Citation : Horton JS, Buckley CL, Stokes AJ. (2013)
Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in mice.
Channels (Austin) 7(1):17-22.
Abstract : Heart failure is becoming a global epidemic. It exerts a staggering toll on quality of life, and substantial medical and economic impact. In a pre-clinical model of cardiac hypertrophy and heart failure, we were able to overcome loss of heart function by administering the TRPV1 antagonist BCTC (4-(3-Chloro-2-pyridinyl)-N-[4-(1,1-dimethylethyl)phenyl]-1-piperazinecarboxamide). The results presented here identify TRPV1 antagonists as new treatment options for cardiac hypertrophy and heart failure.
URL Link : http://www.ncbi.nlm.nih.gov/pubmed/23221478
PMID : 23221478
PMCID : PMC3589277
News
23 July 2018:
2018 Health Disparities Research Institute

Apply Now to the 2018 Health Disparities Research Institute!

The National Institute on Minority Health and Health Disparities (NIMHD) will host the…

12 July 2018:
Summer Career Development Workshop July 12-13, Seattle WA

Geographic Management of Cancer Health Disparities (GMap)
Summer Career Development Workshop July 12-13, Seattle WA

We want to hear from you! If h…

05 April 2018:
Meharry Medical College will host a Grant Writing Workshop on April 5-6, 2018

Meharry Translational Research Center (MeTRC), in conjunction with Office of Minority Health Resource Center (OMHRC), will host a Grant Writing Worksh…


View more news...


Seminars & Events
18 April 2018, 8am:
ANNUAL BIOMEDICAL SCIENCES and HEALTH DISPARITIES SYMPOSIUM
02 April 2018, 12pm - 2pm:
HEALTH SCIENCES INTERDISCIPLINARY POSTER FESTIVAL
16 March 2018, 5pm:
ANNUAL BIOMEDICAL SCIENCES and HEALTH DISPARITIES SYMPOSIUM - Abstract Deadline

View more seminars & events...

Supported by a grant from the National Institute on Minority Health and Health Disparities (U54MD007584), National Institutes of Health.